Literature DB >> 10481983

Optimization study for the reversed-phase ion-pair liquid chromatographic determination of nicotine in commercial tobacco products.

L A Ciolino1, J A Turner, H A McCauley, A W Smallwood, T Y Yi.   

Abstract

The availability of published methods for the determination of nicotine in commercial tobacco products based on state-of-the-art chromatographic methods is limited. Nicotine is a diprotic base with pKa's of 3.12 (pyridine ring) and 8.02 (pyrrolidine ring). Other monoprotic and diprotic bases are also present in commercial tobacco including anatabine, nornicotine, anabasine, and cotinine. In this paper, the chromatography of nicotine and the minor tobacco alkaloids under reversed-phase ion-pairing conditions is thoroughly studied. The results of this study are used to understand the retention mechanisms of the tobacco alkaloids, to examine their observed elution order with respect to fundamental analyte properties (size, functionality, and acid-base strength), and to select optimum chromatographic conditions for the determination of nicotine in commercial tobacco products.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10481983     DOI: 10.1016/s0021-9673(99)00639-1

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  2 in total

1.  Development of a Cigarette Tobacco Filler Standard Reference Material.

Authors:  Lane C Sander; Jeanita S Pritchett; Yasmine C Daniels; Laura J Wood; Brian E Lang; Stephen A Wise; James H Yen; Tricia L Johnson; Matthew J Walters; Tracy Phillips; Matthew R Holman; Grace E Lee; Joseph G Lisko; Brian Lane; Liza Valentin-Blasini; Clifford Watson
Journal:  Anal Chem       Date:  2017-09-20       Impact factor: 6.986

2.  A Stability Indicating HPLC Method to Determine Actual Content and Stability of Nicotine within Electronic Cigarette Liquids.

Authors:  Mahima Bansal; Manisha Sharma; Chris Bullen; Darren Svirskis
Journal:  Int J Environ Res Public Health       Date:  2018-08-13       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.